Experience

LB Pharmaceuticals Announces $285 Million Upsized IPO

September 12, 2025

Cooley advised LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases including schizophrenia, on its $285 million upsized initial public offering (IPO).

Read more

Related contacts

Brandon W. Fenn
Partner, New York
Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Minkyu Park
Special Counsel, New York
Denny Xu
Associate, Boston
Danbi Kim
Associate, Boston
Ariane A. Andrade
Partner, Chicago
Nathaniel Hearn Jr.
Associate, Chicago
Karun Ahuja
Special Counsel, Chicago
Brandon Lefebvre
Quantitative Analyst, Boston
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
Eileen Marshall
Partner, Washington, DC
Phil Mitchell
Partner, New York
Gerard O'Shea
Partner, New York
David Peinsipp
Partner, San Francisco
Ryan Vann
Partner, Chicago
Francis Wheeler
Senior Counsel, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Jessica Koffel
Special Counsel, Brussels
Rebecca Ross
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Chelsea Braun
Associate, Boston
Cara Buchicchio
Associate, New York
David Dalton
Associate, Santa Monica
Vince Flynn
Associate, San Diego
Virat Gupta
Associate, Washington, DC
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Brenna McGuire
Associate, Washington, DC
Sarah Miller
Associate, New York
Jayne M. Munger
Associate, New York
Miles Patton
Associate, New York
Alla Kagan
Paralegal Specialist, San Diego
Cathy Rude
Paralegal Specialist, Boston
Jake Ironfield
Transactional Quantitative Analyst, New York
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Heartflow Announces $364.2 Million Upsized IPO

August 11, 2025

Cooley advised the underwriters of Heartflow, a leader in artificial intelligence technology for coronary artery disease, in connection with Heartflow’s $364.2 million upsized initial public offering.

Read more

Related contacts

David Peinsipp
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Charlie Kim
Partner, San Diego
Denny Won
Partner, San Francisco
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Eric Greig
Partner, Washington, DC
Joanna Liebes Hubberts
Partner, San Diego
Dr. Madhuri Roy
Partner, Palo Alto
Rebecca Ross
Special Counsel, Washington, DC
Barbara Mirza
Partner, Santa Monica
Xander Lee
Partner, Santa Monica
Jane Adams
Partner, San Diego
Annie Froehlich
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Francis Wheeler
Senior Counsel, Colorado
Jessica Koffel
Special Counsel, Brussels
Dillon Martinson
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Max Gonzalez
Associate, Palo Alto
Peter A. Haddad
Associate, San Diego
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Ryan Lewis
Associate, Colorado
Tyler Saavedra-Buckley
Associate, San Francisco
Valerie Sapozhnikova
Associate, Los Angeles

Related Practices & Industries

Beta Bionics Announces Upsized $234.6 Million IPO, Concurrent $17 Million Private Placement

January 31, 2025

Cooley represented Beta Bionics, a pioneering leader in the development of advanced diabetes management solutions, in its $234.6 million initial public offering and concurrent $17 million private placement.

Read more

Related contacts

Carlos Ramirez
Partner, San Diego
Mark Weeks
Partner, Palo Alto
Charlie Kim
Partner, San Diego
Christine S. Kim
Associate, San Diego
Heidi E. Wang
Associate, San Diego
Alexis Guillermo Buz
Associate, San Diego
Joanna Zhang
Associate, San Diego
Jessica Wade
Paralegal Specialist, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Sarah Miller
Associate, New York
Jessica Koffel
Special Counsel, Brussels
Thomas Welk
Senior Counsel, San Diego
Dani Nazemian
Special Counsel, San Diego
Ross Eberly
Partner, Santa Monica
Joanna Liebes Hubberts
Partner, San Diego
Alexandra Paterson
Associate, London
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Stephanie Gentile
Partner, New York
Calvin Lee
Associate, New York
Michael Egan
Partner, Washington, DC
Tania Soris
Associate, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Francis Wheeler
Senior Counsel, Colorado

Related Practices & Industries

Upstream Bio Announces Upsized $293 Million IPO

October 15, 2024

Cooley advised the underwriters of Upstream Bio, a clinical-stage biotech developing a monoclonal antibody to target respiratory disorders, on its upsized $293 million initial public offering.

Read more

Related contacts

Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Claire Keast-Butler
Co-Partner in Charge – London, London
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Dr. Madhuri Roy
Partner, Palo Alto
Francis Wheeler
Senior Counsel, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Megan Drill
Associate, San Diego
Zack Gong
Associate, Shanghai
Peter A. Haddad
Associate, San Diego
David D. Kim
Associate, San Francisco
Jessica Koffel
Special Counsel, Brussels
Sarah Miller
Associate, New York
Lawrence Traylor
Associate, Santa Monica

Related Practices & Industries

Allorion Therapeutics Announces Exclusive Option, Global License Agreement With AstraZeneca

January 2, 2024

Cooley advised Allorion Therapeutics, a US- and China-based biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune diseases, on its exclusive option and global license agreement with AstraZeneca to develop and commercialize a novel epidermal growth factor receptor (EGFR) L858R mutated allosteric inhibitor as a potential new treatment for advanced EGFR-mutant non-small-cell lung cancer.

Read more

Related contacts

Marya Postner
Partner, Palo Alto
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Jameson Davis
Associate, Boston
Xander Lee
Partner, Santa Monica
Sharon Connaughton
Special Counsel, Washington, DC
Rachel Thorn
Of counsel, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Jessica Koffel
Special Counsel, Brussels
Robert Eisenbach
Of Counsel, San Francisco

Related Practices & Industries

View more

Admissions and credentials

Brussels (A List)